Pharming Group N.V. (PHGUF)

[nixke]

Pharming Group reports interim financial results for the first nine months of 2018
Compared with the first nine months of 2017 (on a like-for-like basis):

Product revenues up 74% to €97.7 million, operating profit up 144% to €31.0 million, net profit up 131% to 11.7 million
Compared with the last quarter ended 30 June 2018:

Product revenues up 30% to €38.6 million, operating profit up 82% to €14.7 million, net profit up 77% to €5.4 million
Cash increased to €72.2 million (after €7.5m repayment of debt) to invest in key growth drivers